Compare Makmur Berkah Amanda Tbk (AMAN) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Makmur Berkah Amanda Tbk vs Merck Tbk. — how do they compare? Makmur Berkah Amanda Tbk trades at Rp242 (market cap 929.64B, 146.6K 24h volume), while Merck Tbk. trades at Rp3,890 (market cap 1.75T, 29.1K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Makmur Berkah Amanda Tbk is more actively traded (146.6K versus 29.1K). Which is the better fit depends on your goals.
| AMAN | MERK | |
|---|---|---|
Market Cap | 929.64B | 1.75T |
Volume | 146.6K | 29.1K |
Lot | 1.47K | 291 |
Turnover | 34.83M | 113.37M |
Average Price | 237.56 | 3,895.98 |
Value | 34.83M | 113.37M |
Indicative Equilibrium Price | 242 | 3,890 |
Indicative Equilibrium Volume | 13 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Makmur Berkah Amanda Tbk
PT Makmur Berkah Amanda Tbk (previously PT Sidomaju Industri Estate ("Company")) was established based on Deed No.224, dated May 31, 1996 made by Erly Soehandjojo, SH, notary in Jakarta and Notary Deed Number 5 dated July 2, 1997 made Soeharto, SH, notary in Sidoarjo (here in after referred to as " The Deed of Establishment Deed"). The Company has began its commercial operations since May 31, 1996.
Read more on AMAN →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
